Evaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil

被引:35
|
作者
Oliveira-Santos, M. [1 ,2 ]
Verani, J. F. S. [1 ]
Klumb, E. M. [2 ]
Albuquerque, E. M. N. [2 ]
机构
[1] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitativos Saude, Rio De Janeiro, Brazil
[2] Univ Estado Rio de Janeiro, Hosp Univ Pedro Ernesto, BR-20550011 Rio De Janeiro, Brazil
关键词
adherence to drug treatment; systemic lupus erythematosus; hierarchical multivariate analysis; RECOMMENDATIONS; MEDICATIONS; AMERICAN;
D O I
10.1177/0961203310383736
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objectives of this study were to measure the prevalence of adherence to drug treatment and analyze associations with characteristics pertaining to the treatment, disease, health professionals and services, and socio-demographic issues in patients with systemic lupus erythematosus (SLE) in the city of Rio de Janeiro, Brazil. A sample of 246 women with SLE was analyzed. The data were collected through individual interviews and a review of patient charts. Adherence was estimated according to the Morisk criteria, and the associated factors were analyzed by hierarchical modeling. The percentage of patients classified as adherent to treatment was 31.7%. The reasons cited for non-adherence were: carelessness with drug administration times (52.43%), forgetfulness (38.21%), adverse drug reaction (13.8%), and interruption of treatment due to improvement in symptoms (7.72%). Factors associated with adherence were: behavior towards the presence of adverse drug reaction, hematological alterations, presence of mucocutaneous manifestations, legibility of the medical prescription, schooling, and family support. The study concludes that adherence to drug treatment in SLE is a complex and multifactorial phenomenon, and the results corroborate findings from studies conducted in developed countries. The hierarchical modeling proved to be a good alternative for evaluating adherence, since it allowed visualizing the various stages in the analysis. Lupus (2011) 20, 320-329.
引用
收藏
页码:320 / 329
页数:10
相关论文
共 50 条
  • [31] IMAGING EVALUATION OF JOINTS PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tucaliuc, Simona
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2014, 118 (03): : 711 - 711
  • [32] Treatment of systemic lupus erythematosus
    Mosca, M
    Ruiz-Irastorza, G
    Khamashta, MA
    Hughes, GRV
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (06) : 1065 - 1075
  • [33] Treatment of systemic lupus erythematosus
    Kabelitz, D
    Kremer, B
    Lode, H
    Meinertz, T
    Sauerbruch, T
    Sterry, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 121 (37) : 1129 - 1133
  • [34] Treatment of systemic lupus erythematosus
    McKeon, Kathryn P.
    Jiang, Simon H.
    AUSTRALIAN PRESCRIBER, 2020, 43 (03) : 85 - 90
  • [35] Treatment of systemic lupus erythematosus
    Amoura, Z.
    Piette, J. -C.
    REVUE DE MEDECINE INTERNE, 2007, 28 : S306 - S309
  • [36] TREATMENT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WITHOUT GLUCOCORTICOIDS
    Nikishina, N.
    Mesnyankina, A.
    Aseeva, E.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S455 - S456
  • [37] Is sirolimus a treatment option for patients with systemic lupus erythematosus?
    Esatoglu, S. N.
    Seyahi, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (06) : S13 - S13
  • [38] Pycnogenol® efficacy in the treatment of systemic lupus erythematosus patients
    Stefanescu, M
    Matache, C
    Onu, A
    Tanaseanu, S
    Dragomir, C
    Constantinescu, I
    Schönlau, F
    Rohdewald, P
    Szegli, G
    PHYTOTHERAPY RESEARCH, 2001, 15 (08) : 698 - 704
  • [39] Treatment of systemic lupus erythematosus
    Ochsendorf, FR
    Runne, U
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (27) : 877 - 877
  • [40] DRUG ALLERGY IN CHINESE PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    WANG, CR
    CHUANG, CY
    CHEN, CY
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (02) : 399 - 400